Summaries of the Section H (HML) update

Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.

The full Update will be available as a PDF on our website(external link)

The changes will be published in the online HML around the 23rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

19 October 2021 - preview of changes for November 2021

Pharmaceutical	Change
Amisulpride (Sulprix) tab 100 mg	new listing (p’code 2609401)
Aqueous cream (Pharmacy Health SLS-free) crm 100 g	to be delisted 1 April 2022
Aqueous cream crm 500 g	Brand change GEM Aqueous Cream – new listing and addition of PSS (p’code 2615592) Boucher – to be delisted 1 April 2022
Beclomethasone dipropionate (Qvar) aerosol inhaler 50 mcg per dose and 100 mcg per dose, 200 dose	price increase
Bimatoprost (Bimatoprost Multichem) eye drops 0.03%, 3 ml	price increase and addition of PSS
Bortezomib inj 2.5 mg vial	new presentation listing
Calcium gluconate with calcium carbonate tab eff 2.94 g with calcium carbonate 0.3 g (500 mg elemental)	new listing
Cetomacrogol (helathE) crm BP, 100 g	to be delisted 1 April 2022
Ciclopirox olamine (Apo-Ciclopirox) nail soln 8%, 7 ml	to be delisted 1 May 2022
Cinacalcet tab 30 mg and 60 mg	Brand change Cinacalcet Devatis – new listing and addition of PSS Tab 30 mg (p’code 2615517) Tab 60 mg (p’code 2615525) Sensipar tab 30 mg – to be delisted 1 April 2022
Darunavir (Darunavir Mylan) tab 400 mg	new listing of bottle pack (p’code 2591286)
Entacapone tab 200 mg	Brand change Comtan – new listing and addition of PSS (p’code 2536471) Entapone – to be delisted 1 April 2022
Fentanyl (Boucher and Muir) inj 50 mcg per ml, 2 ml ampoule	price increase and addition of PSS
Fentanyl (Boucher and Muir) inj 50 mcg per ml, 10 ml ampoule	addition of PSS
Folic acid tab 0.8 mg	Brand change Folic Acid multichem – new listing (p’code 2610566) Apo-Folic acid – to be delisted 1 May 2022
Flucytosine tab 500 mg	new presentation listing
Gentamicin sulphate (DBL Gentamicin) inj 10 mg per ml, 1 ml ampoule	price increase
Gentamicin sulphate inj 10 mg per ml, 2 ml ampoule	new presentation listing
Ibuprofen (Ethics) oral liq 20 mg per ml, 200 ml	price increase and addition of PSS
Infliximab (Remicade) inj 100 mg	amended restriction criteria
Melatonin tab modified-release 2 mg	Brand change Vigisom – new listing and addition of PSS (p’code 2612593) Circadin – to be delisted 1 April 2022
Methyldopa (Methyldopa Mylan) tab 250 mg	new listing (p’code 2603934)
Nepafenac (Ilevro) eye drops 0.3%	delist delayed to 1 February 2022
Oxybutynin (Apo-Oxybutynin) tab 5 mg	to be delisted 1 May 2022
Prazosin (Apo-Prazosin) tab 1 mg, 2 mg and 5 mg	removal of restriction
Prazosin (Apo-Prazosin S29) tab 1 mg, 2 mg and 5 mg	new listing Tab 1 mg (p’code 2625725) Tab 2 mg (p’code 2625733) Tab 5 mg (p’code 2625741)
Pyridoxine hydrochloride tab 50 mg	Brand change Pyridoxine multichem – new listing (p’code 2610582) Apo-Pyridoxine – to be delisted 1 May 2022
Rituximab (Riximyo) inj 10 mg per ml, 10 ml vial and inj 10 mg per ml, 50 ml vial	amended restriction criteria
Rivastigmine (Generic Partners) patch 9.5 mg per 24 hour	price decrease
Secukinumab (Cosentyx) inj 150 mg per ml, 1 ml prefilled syringe	amended restriction criteria
Sodium chloride (Baxter-Viaflo) inj 0.9%, 50 ml bag and 100 ml bag	new listing Inj 0.9%, 50 ml bag, 75 bags (p’code 2625857) Inj 0.9%, 100 ml bag, 60 bags (p’code 2625865)
Testosterone undecanoate (Andriol Testocaps) cap 40 mg	addition of restriction
Zinc and castor oil (Boucher) oint, 500 g	price increase

Find previous months' summaries